BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23157406)

  • 21. An overview of proteomic and metabolomic technologies and their application to pregnancy research.
    Horgan RP; Clancy OH; Myers JE; Baker PN
    BJOG; 2009 Jan; 116(2):173-81. PubMed ID: 19076949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipidomic insight into cardiovascular diseases.
    Kohno S; Keenan AL; Ntambi JM; Miyazaki M
    Biochem Biophys Res Commun; 2018 Oct; 504(3):590-595. PubMed ID: 29665359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of metabolomics approaches to the study of respiratory diseases.
    Snowden S; Dahlén SE; Wheelock CE
    Bioanalysis; 2012 Sep; 4(18):2265-90. PubMed ID: 23046268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies.
    Elwood PC; Pickering JE; Hughes J; Fehily AM; Ness AR
    Eur J Clin Nutr; 2004 May; 58(5):718-24. PubMed ID: 15116074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipidomics Insights in Health and Nutritional Intervention Studies.
    Ibáñez C; Mouhid L; Reglero G; Ramírez de Molina A
    J Agric Food Chem; 2017 Sep; 65(36):7827-7842. PubMed ID: 28805384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenge of blood pressure control in patients with ischaemic heart disease in Europe.
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Czarnecka D
    Blood Press Suppl; 2005 Dec; 2():6-9. PubMed ID: 16429635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in metabolite identification.
    Wishart DS
    Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy.
    Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Pedersen AT
    Maturitas; 2006 Jan; 53(2):226-33. PubMed ID: 15955642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomic strategies to study lipotoxicity in cardiovascular disease.
    Waterman CL; Kian-Kai C; Griffin JL
    Biochim Biophys Acta; 2010 Mar; 1801(3):230-4. PubMed ID: 19944186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetics in ischaemic heart disease].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2007 Jul; 23(133):5-8. PubMed ID: 18051822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):142-6. PubMed ID: 14575014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
    Weljie AM; Jirik FR
    Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS₂ score.
    Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
    Thromb Haemost; 2011 Apr; 105(4):712-20. PubMed ID: 21301786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clothing size as an indicator of adiposity, ischaemic heart disease and cardiovascular risks.
    Han TS; Gates E; Truscott E; Lean ME
    J Hum Nutr Diet; 2005 Dec; 18(6):423-30. PubMed ID: 16351701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomics: towards understanding traditional Chinese medicine.
    Zhang A; Sun H; Wang Z; Sun W; Wang P; Wang X
    Planta Med; 2010 Dec; 76(17):2026-35. PubMed ID: 21058239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional genomics for the characterization of the effect of bioactive molecules in lipid metabolism and related pathways.
    Daimiel L; Vargas T; Ramírez de Molina A
    Electrophoresis; 2012 Aug; 33(15):2266-89. PubMed ID: 22887150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics of cancer.
    Serkova NJ; Glunde K
    Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A matter of fat: an introduction to lipidomic profiling methods.
    Roberts LD; McCombie G; Titman CM; Griffin JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):174-81. PubMed ID: 18458005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.